These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 23284892)

  • 1. Myocardial connective tissue growth factor (CCN2/CTGF) attenuates left ventricular remodeling after myocardial infarction.
    Gravning J; Ørn S; Kaasbøll OJ; Martinov VN; Manhenke C; Dickstein K; Edvardsen T; Attramadal H; Ahmed MS
    PLoS One; 2012; 7(12):e52120. PubMed ID: 23284892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload.
    Gravning J; Ahmed MS; von Lueder TG; Edvardsen T; Attramadal H
    Int J Cardiol; 2013 Oct; 168(3):2049-56. PubMed ID: 23452880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased C-reactive protein expression exacerbates left ventricular dysfunction and remodeling after myocardial infarction.
    Takahashi T; Anzai T; Kaneko H; Mano Y; Anzai A; Nagai T; Kohno T; Maekawa Y; Yoshikawa T; Fukuda K; Ogawa S
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1795-804. PubMed ID: 20852043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpressed connective tissue growth factor in cardiomyocytes attenuates left ventricular remodeling induced by angiotensin II perfusion.
    Zhang Y; Yan H; Guang GC; Deng ZR
    Clin Exp Hypertens; 2017; 39(2):168-174. PubMed ID: 28287886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of dietary iron restriction with left ventricular remodeling after myocardial infarction in mice.
    Eguchi A; Naito Y; Iwasaku T; Okuhara Y; Morisawa D; Sawada H; Nishimura K; Oboshi M; Fujii K; Mano T; Masuyama T; Hirotani S
    Heart Vessels; 2016 Feb; 31(2):222-9. PubMed ID: 25573257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac-specific overexpression of diacylglycerol kinase zeta attenuates left ventricular remodeling and improves survival after myocardial infarction.
    Niizeki T; Takeishi Y; Arimoto T; Takahashi H; Shishido T; Koyama Y; Goto K; Walsh RA; Kubota I
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1105-12. PubMed ID: 17071729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac hypertrophy limits infarct expansion after myocardial infarction in mice.
    Iismaa SE; Li M; Kesteven S; Wu J; Chan AY; Holman SR; Calvert JW; Haq AU; Nicks AM; Naqvi N; Husain A; Feneley MP; Graham RM
    Sci Rep; 2018 Apr; 8(1):6114. PubMed ID: 29666426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
    Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A
    Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of novel cardioprotective functions of CCN2/CTGF in myocardial ischemia-reperfusion injury.
    Ahmed MS; Gravning J; Martinov VN; von Lueder TG; Edvardsen T; Czibik G; Moe IT; Vinge LE; Øie E; Valen G; Attramadal H
    Am J Physiol Heart Circ Physiol; 2011 Apr; 300(4):H1291-302. PubMed ID: 21186275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous miR-144 reduces left ventricular remodeling after myocardial infarction.
    Li J; Cai SX; He Q; Zhang H; Friedberg D; Wang F; Redington AN
    Basic Res Cardiol; 2018 Aug; 113(5):36. PubMed ID: 30084039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
    Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-expression of calpastatin inhibits calpain activation and attenuates post-infarction myocardial remodeling.
    Ye T; Wang Q; Zhang Y; Song X; Yang D; Li D; Li D; Su L; Yang Y; Ma S
    PLoS One; 2015; 10(3):e0120178. PubMed ID: 25786109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
    Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
    Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liraglutide improves myocardial fibrosis after myocardial infarction through inhibition of CTGF by activating cAMP in mice.
    Huang DD; Huang HF; Yang Q; Chen XQ
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4648-4656. PubMed ID: 30058704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxia telangiectasia-mutated kinase deficiency exacerbates left ventricular dysfunction and remodeling late after myocardial infarction.
    Daniel LL; Scofield SL; Thrasher P; Dalal S; Daniels CR; Foster CR; Singh M; Singh K
    Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H445-52. PubMed ID: 27288435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calpastatin overexpression impairs postinfarct scar healing in mice by compromising reparative immune cell recruitment and activation.
    Wan F; Letavernier E; Le Saux CJ; Houssaini A; Abid S; Czibik G; Sawaki D; Marcos E; Dubois-Rande JL; Baud L; Adnot S; Derumeaux G; Gellen B
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1883-93. PubMed ID: 26453333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
    Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
    Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction.
    Xiao J; Moon M; Yan L; Nian M; Zhang Y; Liu C; Lu J; Guan H; Chen M; Jiang D; Jiang H; Liu PP; Li H
    Basic Res Cardiol; 2012 Jan; 107(1):239. PubMed ID: 22202974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival.
    Du XJ; Gao XM; Kiriazis H; Moore XL; Ming Z; Su Y; Finch AM; Hannan RA; Dart AM; Graham RM
    Cardiovasc Res; 2006 Sep; 71(4):735-43. PubMed ID: 16859660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Thyrotropin-releasing Hormone Inhibition Improves Ventricular Function and Reduces Hypertrophy and Fibrosis After Myocardial Infarction in Rats.
    Schuman ML; Peres Diaz LS; Aisicovich M; Ingallina F; Toblli JE; Landa MS; García SI
    J Card Fail; 2021 Jul; 27(7):796-807. PubMed ID: 33865967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.